Nesiritide therapy in a term neonate with renal disease

Pharmacotherapy

Volumn 26, Issue 2, 2006, Pages 281-284

  Moffett, Brady S ^a   Jefferies, John L ^b   Rossano, Joseph ^b   Towbin, Jeffrey A ^b  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Heart failure; Neonate; Nesiritide; Polycystic kidney disease

Indexed keywords

ACETAZOLAMIDE; BRAIN NATRIURETIC PEPTIDE; FUROSEMIDE; LOOP DIURETIC AGENT; NESIRITIDE; NIFEDIPINE;

ABSENCE OF SIDE EFFECTS; ANURIA; ARTICLE; CASE REPORT; DOSE CALCULATION; DOSE RESPONSE; DRUG INFUSION; HEART FAILURE; HEART FUNCTION; HUMAN; HYPERTENSION; HYPOTENSION; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; MALE; NEWBORN; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS; URINE VOLUME;

BLOOD UREA NITROGEN; DIURETICS; ELECTROCARDIOGRAPHY; FATAL OUTCOME; HEART DEFECTS, CONGENITAL; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION, PULMONARY; INFANT, NEWBORN; MALE; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN; POLYCYSTIC KIDNEY DISEASES;

EID: 32044453820     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.26.2.281     Document Type: Article

References (11)

1. Colucci WS, Elkayam U, Horton DP, et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure: nesiritide study group. N Engl J Med 2000;343:246-53.
2. Zineh I, Schofield RS, Johnson JA. The evolving role of nesiritide in advanced or decompensated heart failure. Pharmacotherapy 2003;23:1266-80.
3. Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF). Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA 2002;287:1531-40.
4. Burger AJ, Horton DP, Lejemtel T, et al. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study. Am Heart J 2002;144:1102-8.
5. Feingold B, Law YM. Use of nesiritide in pediatric patients with congestive heart failure. J Heart Lung Transplant 2004;23:1455-9.
6. Marshall J, Berkenbosch JW, Russo P, Tobias JD. Preliminary experience with nesiritide in the pediatric population. J Intensive Care Med 2004;19:164-70.
7. Simsic JM, Reddy VS, Kanter KR, Kirshbom PM, Forbess JM. Use of nesiritide (human B-type natriuretic peptide) in infants following cardiac surgery. Pediatr Cardiol 2004;25:668-70.
8. Sehra R, Underwood K. Nesiritide improves urine output in severely ill pediatric patients awaiting heart transplant without severe hypotension [abstr]. J Card Fail 2003;5:254.
9. Smith T, Rosen DA, Russo P, et al. Nesiritide during extracorporeal membrane oxygenation. Paediatr Anaesth 2005;15:152-7.
10. Wang DJ, Dowling TC, Meadows D, et al. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine. Circulation 2004;110:1620-5.
11. Sackner-Bernstein JD, Skopicki HA, Aaronson KD. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 2005;111:1487-91.